Vascular Imaging With Ferumoxytol as a Contrast Agent.

Hope, Michael D; Hope, Thomas A; Zhu, Chengcheng; Faraji, Farshid; Haraldsson, Henrik; Ordovas, Karen G; Saloner, David

Hope, Michael D; Hope, Thomas A; Zhu, Chengcheng; Faraji, Farshid; Haraldsson, Henrik; Ordovas, Karen G; Saloner, David.

Afiliação

Hope MD; 1 All authors: Department of Radiology, University of California, San Francisco, 505 Parnassus Ave, Box 0628, San Francisco, CA 94143-0628.
Hope TA; 1 All authors: Department of Radiology, University of California, San Francisco, 505 Parnassus Ave, Box 0628, San Francisco, CA 94143-0628.
Zhu C; 1 All authors: Department of Radiology, University of California, San Francisco, 505 Parnassus Ave, Box 0628, San Francisco, CA 94143-0628.
Faraji F; 1 All authors: Department of Radiology, University of California, San Francisco, 505 Parnassus Ave, Box 0628, San Francisco, CA 94143-0628.
Haraldsson H; 1 All authors: Department of Radiology, University of California, San Francisco, 505 Parnassus Ave, Box 0628, San Francisco, CA 94143-0628.
Ordovas KG; 1 All authors: Department of Radiology, University of California, San Francisco, 505 Parnassus Ave, Box 0628, San Francisco, CA 94143-0628.
Saloner D; 1 All authors: Department of Radiology, University of California, San Francisco, 505 Parnassus Ave, Box 0628, San Francisco, CA 94143-0628.

AJR Am J Roentgenol ; 205(3): W366-73, 2015 Sep.

Article em En | MEDLINE | ID: mdl-26102308

ABSTRACT

ABSTRACT

OBJECTIVE:

Ferumoxytol is increasingly reported as an alternative to gadolinium-based contrast agents for MR angiography (MRA), particularly for patients with renal failure. This article summarizes more than 3 years of clinical experience with ferumoxytol-enhanced MRA for a range of indications and anatomic regions.

CONCLUSION:

Ferumoxytol-enhanced MRA has many advantages including that it is safe for patients with renal failure and provides a lengthy plateau of vascular signal as a blood pool agent that allows longer navigated MRA sequences.

Assuntos

Meios de Contraste; Óxido Ferroso-Férrico; Angiografia por Ressonância Magnética; Doenças Vasculares/diagnóstico; Idoso; Idoso de 80 Anos ou mais; Feminino; Humanos; Aumento da Imagem; Imageamento Tridimensional; Masculino; Pessoa de Meia-Idade; Estudos Retrospectivos

Palavras-chave

4D flow; MR angiography (MRA); contrast agents; ferumoxytol; inflammation; navigated MRA; ultrasmall superparamagnetic iron oxide (USPIO)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Vasculares / Angiografia por Ressonância Magnética / Meios de Contraste / Óxido Ferroso-Férrico Tipo de estudo: Observational_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: AJR Am J Roentgenol Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google